Literature DB >> 9075002

Center of mass velocity-position predictions for balance control.

Y C Pai1, J Patton.   

Abstract

The purposes of this analysis were to predict the feasible movements during which balance can be maintained, based on environmental (contact force), anatomical (foot geometry), and physiological (muscle strength) constraints, and to identify the role of each constraint in limiting movement. An inverted pendulum model with a foot segment was used with an optimization algorithm to determine the set of feasible center of mass (CM) velocity-position combinations for movement termination. The upper boundary of the resulting feasible region ran from a velocity of 1.1 s-1 (normalized to body height) at 2.4 foot lengths behind the heel, to 0.45 s-1 over the heel, to zero over the toe, and the lower boundary from a velocity of 0.9 s-1 at 2.7 foot lengths behind the heel, to zero over the heel. Forward falls would be initiated if states exceeded the upper boundary, and backward falls would be initiated if the states fell below the lower boundary. Under normal conditions, the constraint on the size of the base of support (BOS) determined the upper and lower boundaries of the feasible region. However, friction and strength did limit the feasible region when friction levels were less than 0.82, when dorsiflexion was reduced more than 51%, or when plantar flexion strength was reduced more than 35%. These findings expand the long-held concept that balance is based on CM position limits (i.e. the horizontal CM position has to be confined within the BOS to guarantee stable standing) to a concept based on CM velocity-position limits.

Entities:  

Mesh:

Year:  1997        PMID: 9075002     DOI: 10.1016/s0021-9290(96)00165-0

Source DB:  PubMed          Journal:  J Biomech        ISSN: 0021-9290            Impact factor:   2.712


  164 in total

1.  Limb collapse, rather than instability, causes failure in sit-to-stand performance among patients with parkinson disease.

Authors:  Margaret K Y Mak; Feng Yang; Yi-Chung Pai
Journal:  Phys Ther       Date:  2011-01-27

2.  Effects of age-related gait changes on the biomechanics of slips and falls.

Authors:  Thurmon E Lockhart; Jeffrey C Woldstad; James L Smith
Journal:  Ergonomics       Date:  2003-10-10       Impact factor: 2.778

3.  Motor strategies for initiating downward-oriented movements during standing in adults.

Authors:  K Hase; M Sako; J Ushiba; N Chino
Journal:  Exp Brain Res       Date:  2004-03-13       Impact factor: 1.972

4.  Effects of moveable platform training in preventing slip-induced falls in older adults.

Authors:  Prakriti Parijat; Thurmon E Lockhart
Journal:  Ann Biomed Eng       Date:  2011-12-02       Impact factor: 3.934

5.  Detecting dynamical boundaries from kinematic data in biomechanics.

Authors:  Shane D Ross; Martin L Tanaka; Carmine Senatore
Journal:  Chaos       Date:  2010-03       Impact factor: 3.642

6.  Relationship between age-related gait adaptations and required coefficient of friction.

Authors:  Sukwon Kim; Thurmon Lockhart; Hoon-Yong Yoon
Journal:  Saf Sci       Date:  2005-08-01       Impact factor: 4.877

7.  Influence of fear of falling on anticipatory postural control of medio-lateral stability during rapid leg flexion.

Authors:  E Yiou; T Deroche; M C Do; T Woodman
Journal:  Eur J Appl Physiol       Date:  2010-10-12       Impact factor: 3.078

8.  Center of mass acceleration feedback control for standing by functional neuromuscular stimulation: a simulation study.

Authors:  Raviraj Nataraj; Musa L Audu; Robert F Kirsch; Ronald J Triolo
Journal:  J Rehabil Res Dev       Date:  2012

9.  Required coefficient of friction during turning at self-selected slow, normal, and fast walking speeds.

Authors:  Peter Fino; Thurmon E Lockhart
Journal:  J Biomech       Date:  2014-02-17       Impact factor: 2.712

10.  Kinematics and postural muscular activity during continuous oscillating platform movement in children and adolescents.

Authors:  Richard S Mills; Heidi Sveistrup
Journal:  Exp Brain Res       Date:  2018-03-17       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.